Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Recruiting

Meibomian Gland ProbingMeibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

Sponsor:

Massachusetts Eye and Ear Infirmary

Code:

NCT05145959

Conditions

Stevens-Johnson Syndrome

Toxic Epidermal Necrolyses

Ocular Surface Disease

Meibomitis

Meibomian Gland Dysfunction

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Maskin Probe

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Massachusetts Eye and Ear Infirmary on 2021-12-06.